OMNI Kudos to Northwestern CSB for SOR III Intake GPRA Numbers

Happy New Year! This year we will continue to share some shout-outs about CSBs or Agencies that are doing well with intakes, follow-ups, engaging and supporting clients, and/or those that demonstrate a "spirit of inquiry" when engaging with our TA Team on GPRA administration issues.

This month, we’d like to highlight Northwestern CSB. Over the past couple of months, this CSB managed to exceed their year 1 GPRA intake target within the first couple of months of the current grant year. Kudos!

We know that everyone is working hard toward meeting their intake goal as set out by DBHDS this year. If you have questions about this or need support with any aspect of GPRA administration, please reach out to our team at OMNI: SORsupport@omni.org

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.